“…The conventional perfusion strategy, which employs non-thromboresistant bypass circuits and high-dose heparin used in the vast majority of the cardiopulmonary bypass based cardiac surgeries, incites strong inflammatory responses [5,11,12], hemolytic turbulence, and significant activation of the coagulation and fibrinolytic systems during and after the procedure [4,[13][14][15]. Multiple measures were taken clinically to alleviate these potentially harmful responses, using pharmacologic agents [16][17][18][19], mechanical means such as leukocytes filters [20], various compounds and methods for surface coatings [21], or eliminating the foreign surfaces by performing ''off-pump'' coronary bypass grafting [21].…”